New

ETF model portfolios designed for real investor needs. Discover →

Advertisement

BROUGHT TO YOU BY:

NYSE logoTrackinsight logo
ETF Central logo

BROUGHT TO YOU BY:

NYSE logoTrackinsight logo
ETF Central logo
ETF Portfolio Builder
New
ETF Central logo
ETF Portfolio Builder
New
Advertisement

IBBvsETF 2ETF Comparison

ETF 1
IBB

iShares Biotechnology ETF

This fund is part of
US Health Care
-0.42%
Full IBB fund page
VS
ETF 2
Suggested IBB comparisons
IBBQFBTTMEDGNOMGNMXHTECGDOCPBEWDNAIHE

Choose a second ETF to run a side-by-side ETF comparison with IBB, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IBB performance and flow charts

Performance

0.02.04.06.08.0%Aug 10Aug 17Aug 24Aug 31Sep 8

Cumulative Flows

0 M50 M100 M150 M200 M250 MAug 10Aug 17Aug 24Aug 31Sep 8

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Trackinsight logo
Data Services
Historic performance and flows
Data as of 09/08/2026
1M3MYTD1Y3Y5Y
Perf.
IBB
ETF 2
+3.63%–
+24.21%–
+22.91%–
+46.14%–
+64.83%–
+20.96%–
Flows
IBB
ETF 2
+$258M–
+$788M–
+$302M–
+$1.81B–
-$580M–
-$1.46B–
Volatility and drawdown
3M1Y3Y5Y
Volatility
IBB
ETF 2
+24.71%–
+21.85%–
+21.06%–
+22.47%–
Max drawdown
IBB
ETF 2
-6.21%–
-9.61%–
-24.82%–
-38.96%–
Max drawdown duration
IBB
ETF 2
31d–
151d–
377d–
1523d–
Trading data

Create an account to view trading data

Join for free
IBB
ETF 2
Last sale
9/10/2026 at 1:30 PM
$202.64
–
Previous close
09/09/2026
$205.49
–
Consolidated volume
09/09/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IBB
ETF 2
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/10/2026 at 1:30 PM
Live
Closed
IBB
ETF 2
Last price
$202.64
–
1D performance
-1.39%
–
AuM$10.50 B–
E/R0.44%–
Characteristics
IBB
ETF 2
Management strategyPassive–
ProvideriShares–
BenchmarkICE Biotechnology Index–
N° of holdings240–
Asset classEquities–
Trailing 12m distribution yield
Join
Join
Inception dateFebruary 5, 2001–
ESGNo–
TrackinsightTrackinsight

More IBB data on Trackinsight

ETF 2
Advertisement
Exposure

Countries

IBB
USA
86.04%
Other
13.96%
ETF 2

Sectors

IBB
Healthcare
99.83%
Other
0.17%
ETF 2

Diversification

IBB

Total weight of top 15 holdings out of 15

54.48%
ETF 2
–

Top 15 holdings

Data as of July 31, 2026
IBB
Amgen, Inc.
8.42%
Vertex Pharmaceuticals, Inc.
7.87%
Gilead Sciences, Inc.
7.14%
Regeneron Pharmaceuticals, Inc.
5.84%
argenx SE
3.55%
Natera, Inc.
2.88%
Revolution Medicines, Inc.
2.87%
Illumina, Inc.
2.42%
Biogen, Inc.
2.38%
Alnylam Pharmaceuticals, Inc.
2.14%
BeOne Medicines Ltd.
2.01%
Incyte Corp.
1.91%
Insmed, Inc.
1.71%
United Therapeutics Corp.
1.69%
Moderna, Inc.
1.65%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
Advertisement
ETF CENTRAL
Latest ETF NewsPopular SegmentsETF InstituteCompare ETFsETF Portfolio Builder
New
ETF ScreenerETF UGlobal ETF Survey 2025

BROUGHT TO YOU BY:

NYSE logoTrackinsight logo
In Memoriam: Jean-René Giraud
Privacy policy
|
Terms of use
|
Contact Us
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up